Provided by Tiger Trade Technology Pte. Ltd.

Protagonist Therapeutics

98.97
-3.2000-3.13%
Post-market: 98.970.00000.00%18:11 EDT
Volume:785.51K
Turnover:78.04M
Market Cap:6.32B
PE:-48.28
High:101.92
Open:101.27
Low:97.89
Close:102.17
52wk High:105.69
52wk Low:39.60
Shares:63.81M
Float Shares:43.15M
Volume Ratio:0.68
T/O Rate:1.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0500
EPS(LYR):-2.0500
ROE:-20.18%
ROA:-13.99%
PB:10.27
PE(LYR):-48.28

Loading ...

High Growth US Tech Stocks To Watch In October 2025

Simply Wall St.
·
Oct 14, 2025

Johnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To Watch

Benzinga_recent_news
·
Oct 14, 2025

FDA Adds New Warning For Johnson & Johnson's Cancer Cell Therapy

Benzinga
·
Oct 13, 2025

BUZZ-Street View: Protagonist's 'main character' energy draws J&J to potential takeover talks

Reuters
·
Oct 13, 2025

Protagonist Therapeutics (PTGX) Gets a Buy from BMO Capital

TIPRANKS
·
Oct 13, 2025

Protagonist Therapeutics (PTGX) Gets a Buy from Truist Financial

TIPRANKS
·
Oct 13, 2025

Protagonist Therapeutics Inc : Bmo Raises Target Price to $112 From $72

THOMSON REUTERS
·
Oct 13, 2025

U.S. Stocks to Watch: MP Materials, Nvidia, AMD, Tesla, Alibaba, Fastenal, and More

Dow Jones
·
Oct 13, 2025

Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today

Motley Fool
·
Oct 11, 2025

Deals of the day-Mergers and acquisitions

Reuters
·
Oct 11, 2025

Sector Update: Health Care Stocks Decline Friday Afternoon

MT Newswires Live
·
Oct 11, 2025

Dow Jones Top Company Headlines at 1 PM ET: Johnson & Johnson in Talks to Buy Protagonist Therapeutics | Canada, ...

Dow Jones
·
Oct 11, 2025

M&A News: Protagonist Therapeutics Stock (PTGX) is Star of the Show on JNJ Bid Talk

TIPRANKS
·
Oct 11, 2025

Protagonist Therapeutics rises 34.1%

TIPRANKS
·
Oct 11, 2025

Protagonist Therapeutics Shares Extend Gains, Last up 34%

THOMSON REUTERS
·
Oct 11, 2025

Top Midday Stories: Trump Threatens 'Massive' Tariff Raise on China; Nvidia Chips Face Higher Scrutiny at China Customs

MT Newswires Live
·
Oct 10, 2025

BUZZ-Protagonist Therapeutics surges after media reports J&J in talks to buy co

Reuters
·
Oct 10, 2025

Protagonist Therapeutics resumes, up 28% after report of J&J takeover talks

TIPRANKS
·
Oct 10, 2025

Market Chatter: Johnson & Johnson in Talks to Acquire Protagonist Therapeutics

MT Newswires Live
·
Oct 10, 2025

Protagonist Therapeutics Shares Rise 9.4% After WSJ Reports Johnson & Johnson in Talks to Buy Co

THOMSON REUTERS
·
Oct 10, 2025